Cora Koch
Overview
Explore the profile of Cora Koch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koch C, Meier S, Fischer C, Brich J
Cerebrovasc Dis
. 2023 Nov;
53(5):564-569.
PMID: 37995665
Introduction: Stroke detection in the preclinical setting is challenging, resulting in more than 1/3 of missed strokes by emergency medical services (EMS) personnel. Recently, prehospital identification of anterior large vessel...
2.
Stoll M, Hubenschmid L, Koch C, Lieb K, Egloff B
BMJ Open
. 2022 Jun;
12(6):e055963.
PMID: 35750457
Objectives: To investigate German physicians' attitudes towards and experiences with voluntary disclosure of payments by pharmaceutical companies in a public database and their impact on future decisions for or against...
3.
4.
Bornkamm K, Koch C, Dietterle J, Steiert M, Fleig A, Weiller C, et al.
Neurology
. 2021 Sep;
97(20):e2032-e2038.
PMID: 34556563
Background And Objectives: To compare a blended learning approach with traditional face-to-face instruction in terms of their individual effectiveness in imparting neurologic examination (NE) skills in medical students. Methods: We...
5.
Koch C, Brich J
BMC Med Educ
. 2020 Nov;
20(1):408.
PMID: 33160334
Background: Conflicts of interest (COIs), including those arising from interactions with pharmaceutical companies, may lead to bias in medical data. Although medical students are now requesting more education on COIs...
6.
Stoll M, Hubenschmid L, Koch C, Lieb K
BMJ Open
. 2020 Sep;
10(9):e037395.
PMID: 32948560
Objective: To analyse voluntary payment reports of pharmaceutical companies to German healthcare professionals (HCPs) in 2015 and 2016 based on an industry-self-regulating transparency codex. Design And Participants: Cohort study of...
7.
Koch C, Schleeff J, Techen F, Wollschlager D, Schott G, Kolbel R, et al.
PLoS Med
. 2020 Jun;
17(6):e1003151.
PMID: 32589633
Background: Non-interventional post-marketing studies (NIPMSs) sponsored by pharmaceutical companies are controversial because, while they are theoretically useful instruments for pharmacovigilance, some authors have hypothesized that they are merely marketing instruments...
8.
Deis N, Koch C, Dreimuller N, Gaitzsch E, Weisskircher J, Junger J, et al.
GMS J Med Educ
. 2020 Apr;
37(1):Doc3.
PMID: 32270017
Insufficient risk competence of physicians, conflicts of interests from interactions with pharmaceutical companies, and the often distorted presentation of benefits and risks of therapies compromise the advising of patients by...
9.
Koch C, Dreimuller N, Weisskircher J, Deis N, Gaitzsch E, Wagner S, et al.
J Gen Intern Med
. 2019 Dec;
35(2):473-480.
PMID: 31823309
Background: Risk communication is a core aspect of a physician's work and a fundamental prerequisite for successful shared decision-making. However, many physicians are not able to adequately communicate risks to...
10.
Dreimuller N, Schenkel S, Stoll M, Koch C, Lieb K, Juenger J
BMC Med Educ
. 2019 May;
19(1):121.
PMID: 31046745
Background: Performing a psychiatric interview and documenting the recorded findings in the form of a brief psychiatric report is one of the main learning goals in the psychiatric curriculum for...